Pharmos Corporation

Company Information
Address 2 INNOVATION DR
Alachua, FL, 32615


Information

DUNS: N/A

# of Employees: N/A


Ownership Information

Hubzone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. PRODRUGS AND AQUEOUS FORMULATIONS OF DEXANABINOL

    Amount: $100,000.00

    N/A

    SBIRPhase I1997Department of Health and Human Services
  2. DEVELOPMENT OF A NONSURFACTANT FORMULATION FOR INDUCING AGENTS

    Amount: $318,778.00

    ADVERSE REACTIONS HAVE BEEN REPORTED TO OCCUR AFTER ADMINISTRATION OF COMPOUNDS SOLUBILIZED IN AQUEOUS VEHICLES. THESE SIDE EFFECTS MAY BE REDUCED OR ELIMINATED BY COMBINING THE PRIMARY INDUCING AGENT ...

    SBIRPhase II1992Department of Health and Human Services
  3. PARENTERAL FORMULATION FOR CARBAMAZEPINE

    Amount: $500,000.00

    THE FAVORABLE EFFICACY, TOXICITY AND ADVERSE SIDE-EFFECT PROFILES OF CARBAMAZEPINE (CBZ) CONTRIBUTE TO ITS WIDESPREADAND INCREASING USE TO CONTROL SEIZURES IN THE EPILETPTIC PATIENTS. HOWEVER, IN CASE ...

    SBIRPhase II1992Department of Health and Human Services
  4. PARENTERAL FORMULATION FOR CARBAMAZEPINE

    Amount: $49,941.00

    N/A

    SBIRPhase I1991Department of Health and Human Services
  5. IMPROVED THERAPY FOR DEPRESSION

    Amount: $50,000.00

    DEPRESSION IS A HETEROGENOUS DISEASE, COVERING A RANGE OF SEVERITY, QUALITIES, AND CAUSES THAT AFFECTS AN IMPORTANT PORTION OF POPULATION. NONE OF THE AVAILABLE TREATMENT MODALITIES OF DEPRESSION, INC ...

    SBIRPhase I1990Department of Health and Human Services
  6. DEVELOPMENT OF A NONSURFACTANT FORMULATION FOR INDUCING AGENTS

    Amount: $45,390.00

    N/A

    SBIRPhase I1990Department of Health and Human Services
  7. CROSS-AXIS COIL PLANET CENTRIFUGE CHROMATOGRAPH DESIGN AND SYNTHESIS OF BRAIN-SPECIFIC ANTIHERPETIC AGENTS

    Amount: $416,005.00

    A NEW COUNTERCURRENT CHROMATOGRAPHY INSTRUMENT, THE CROSS-AXIS FLOW-THROUGH COIL PLANET CENTRIFUGE IS PROPOSED FOR THE PREPARATIVE CHROMATOGRAPHY OF PEPTIDES. THIS IS AN APPARATUS THAT SEPARATES SUBST ...

    SBIRPhase II1989Department of Health and Human Services
  8. IMPROVED THERAPY FOR CNS TOXOPLASMOSIS

    Amount: $50,000.00

    CEREBRAL TOXOPLASMOSIS IS THE MOST COMMON OPPORTUNISTIC DISEASE AFFECTING THE BRAIN OF PATIENTS WITH ACQUIRED IMMUNEDEFICIENCY SYNDROME (AIDS). SULFONAMIDE TREATMENT IS INITIALLY EFFECTIVE IN TREATING ...

    SBIRPhase I1989Department of Health and Human Services
  9. IMPROVED DELIVERY OF ANTIVIRALS FOR CNS INFECTIONS

    Amount: $50,000.00

    HUMAN CYTOMEGALOVIRUS (HCMV) IS A COMMON AND NOT USUALLY SERIOUS INFECTIVE AGENT. HOWEVER, IN THE CASE OF ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) AND OTHER IMMUNO-SUPPRESSEDSTATES, HCMV IS INORDINAT ...

    SBIRPhase I1988Department of Health and Human Services
  10. ORAL DELIVERY OF A SUSTAINED ESTRADIOL DELIVERY SYSTEM

    Amount: $462,000.00

    STUDIES ARE PROPOSED TO EVALUATE THE FEASIBILITY OF ORAL 17BETA-ESTRADIOL (E2) ADMINISTRATION USING A NOVEL REDOX SYSTEM. THIS CHEMICAL DELIVERY SYSTEM (CDS) IS BASED ON AN INTERCONVERSION OF A LIPOPH ...

    SBIRPhase II1988Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government